Your browser doesn't support javascript.
Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity.
Han, Shasha; Cai, Jun; Yang, Juan; Zhang, Juanjuan; Wu, Qianhui; Zheng, Wen; Shi, Huilin; Ajelli, Marco; Zhou, Xiao-Hua; Yu, Hongjie.
  • Han S; Beijing International Center for Mathematical Research, Peking University, Beijing, China.
  • Cai J; Harvard Medical School, Harvard University, Boston, MA, USA.
  • Yang J; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Zhang J; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Wu Q; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
  • Zheng W; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Shi H; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Ajelli M; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Zhou XH; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Yu H; Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA.
Nat Commun ; 12(1): 4673, 2021 08 03.
Artículo en Inglés | MEDLINE | ID: covidwho-1340997
ABSTRACT
Dynamically adapting the allocation of COVID-19 vaccines to the evolving epidemiological situation could be key to reduce COVID-19 burden. Here we developed a data-driven mechanistic model of SARS-CoV-2 transmission to explore optimal vaccine prioritization strategies in China. We found that a time-varying vaccination program (i.e., allocating vaccines to different target groups as the epidemic evolves) can be highly beneficial as it is capable of simultaneously achieving different objectives (e.g., minimizing the number of deaths and of infections). Our findings suggest that boosting the vaccination capacity up to 2.5 million first doses per day (0.17% rollout speed) or higher could greatly reduce COVID-19 burden, should a new wave start to unfold in China with reproduction number ≤1.5. The highest priority categories are consistent under a broad range of assumptions. Finally, a high vaccination capacity in the early phase of the vaccination campaign is key to achieve large gains of strategic prioritizations.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Asignación de Recursos para la Atención de Salud / Vacunación Masiva / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Estudio experimental / Estudio observacional / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos País/Región como asunto: Asia Idioma: Inglés Revista: Nat Commun Asunto de la revista: Biologia / Ciencia Año: 2021 Tipo del documento: Artículo País de afiliación: S41467-021-24872-5

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Asignación de Recursos para la Atención de Salud / Vacunación Masiva / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Estudio experimental / Estudio observacional / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos País/Región como asunto: Asia Idioma: Inglés Revista: Nat Commun Asunto de la revista: Biologia / Ciencia Año: 2021 Tipo del documento: Artículo País de afiliación: S41467-021-24872-5